Pregabalin is moderately effective for generalized anxiety disorder (GAD), with a pooled effect size of 0.36 in meta-analysis. That places it in the “small to moderate” range, roughly comparable to SSRIs and SNRIs. It’s not a first-line treatment in most guidelines, but it works noticeably faster than antidepressants, with measurable anxiety reduction appearing within the first week of treatment.
How Well It Works by the Numbers
A meta-analysis of pregabalin trials in GAD found an overall effect size of 0.36, which in clinical research terms falls between “small” and “moderate.” To put that in perspective, most SSRIs and SNRIs for anxiety land in a similar range. The effect was slightly stronger for mental symptoms of anxiety (racing thoughts, excessive worry) at 0.35, while physical symptoms like muscle tension and restlessness saw a smaller benefit at 0.24.
In a head-to-head trial comparing pregabalin to venlafaxine (an SNRI), both medications reduced anxiety scores by similar amounts after six weeks. Pregabalin at 400 mg daily lowered scores on a standard anxiety rating scale by 14.7 points compared to 11.6 for placebo. Venlafaxine at 75 mg daily reduced scores by 14.1 points. Both were statistically better than placebo, and they were close to each other by the end of the trial.
Faster Onset Than Antidepressants
The biggest practical advantage of pregabalin is speed. Significant anxiety relief showed up as early as the first week of treatment in clinical trials. That’s a meaningful difference from SSRIs and SNRIs, which typically take two to four weeks (sometimes longer) before patients feel improvement. In the comparison trial, both doses of pregabalin outperformed venlafaxine at the one-week mark on overall anxiety scores, mental anxiety symptoms, and physical anxiety symptoms.
The speed of onset was comparable to lorazepam (a benzodiazepine), which is notable because pregabalin carries a lower risk of the kind of physical dependence associated with benzodiazepines. For people who need relief quickly but want to avoid a benzodiazepine, this is one of the main reasons prescribers consider pregabalin.
Where It Fits in Treatment Guidelines
The UK’s National Institute for Health and Care Excellence (NICE) positions pregabalin as a second-line option for GAD. Their recommendation is straightforward: consider pregabalin if you cannot tolerate SSRIs or SNRIs. This means it’s not typically the first medication a doctor will suggest, but it’s a well-established alternative when first-line drugs cause intolerable side effects or don’t work.
Pregabalin has also been studied in social anxiety disorder and panic disorder, though the evidence base is strongest for GAD. For social anxiety and panic, clinical algorithms suggest similar dosing, and some studies have shown benefit, but it’s used more as an add-on therapy in those conditions rather than a standalone treatment.
Typical Doses for Anxiety
Treatment usually starts low, at 25 to 50 mg taken at bedtime, then increases gradually by 25 to 50 mg per week. The target dose for GAD is around 150 mg daily, split into two or three doses. Some people need more, and doses up to 600 mg daily have shown effectiveness in trials. In the head-to-head study against venlafaxine, both 400 mg and 600 mg daily doses worked well, with the 400 mg dose actually producing the largest score reduction.
If daytime drowsiness is a problem, consolidating the full dose at bedtime is a common adjustment. The slow upward titration helps your body adjust and reduces the chance of early side effects driving you to stop the medication.
Common Side Effects
The most frequently reported side effects are drowsiness, dizziness, and weight gain. These tend to be most noticeable when starting the medication or increasing the dose. In the comparison trial with venlafaxine, pregabalin at 400 mg daily had a notably low dropout rate due to side effects: only 6%, compared to 20% for venlafaxine. At the higher 600 mg dose, the dropout rate rose to 14%, which was still lower than venlafaxine.
Weight gain is worth knowing about upfront. It’s listed among the more common side effects and can be an ongoing issue rather than something that fades after the first few weeks. Unsteadiness or clumsiness is another effect some people notice, particularly at higher doses. For many people these side effects are manageable, but they’re the main reason some patients switch to a different medication.
Long-Term Use and Stopping
A study tracking patients through 12 and 24 weeks of treatment found that pregabalin maintained its effectiveness over time without requiring dose increases. When patients stopped the medication after these periods, rebound anxiety (where anxiety temporarily spikes above its original level) was uncommon. After 12 weeks of treatment, rebound rates ranged from about 2% to 5% depending on the dose. After 24 weeks, rates were 0% to 4% for pregabalin, compared to 6% for lorazepam.
That said, stopping abruptly is not recommended. The standard guidance is to reduce the daily dose by no more than 50 to 100 mg per week. A gradual taper lets you and your prescriber watch for any returning symptoms and distinguish between withdrawal effects and the underlying anxiety coming back. Tapering slowly is especially important if you’ve been on a higher dose or have taken the medication for several months.
How It Works in the Brain
Pregabalin doesn’t work like SSRIs, benzodiazepines, or any of the more familiar anxiety medications. It binds to a specific protein on nerve cells that controls calcium flow into the cell. When calcium enters a nerve terminal, it triggers the release of chemical messengers. By reducing calcium influx, pregabalin dials down the release of excitatory signals in overactive brain circuits. This is fundamentally different from, say, an SSRI boosting serotonin levels or a benzodiazepine enhancing the brain’s main calming chemical.
With chronic use, pregabalin appears to reduce the amount of its target protein reaching nerve terminals in the first place, which may explain why it maintains effectiveness over weeks and months rather than wearing off. This mechanism also explains why it works for such different conditions (nerve pain, epilepsy, and anxiety), since all three involve excessive nerve signaling.